Delivery Order SPE2DB20D3303-SPE2DB25FA3AE
Award Date 8/27/25
Potential Completion Date 8/28/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,409.96 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 ml syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price, non-set-aside contract represents a single delivery order fulfillment under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $8,318.78 delivery order to AmerisourceBergen Drug Corp for MONOVISC 88 mg/4 mL syringes (4 mL quantity) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and represents a routine pharmaceutical supply delivery. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $31,334.26 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 7, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $16,244.34 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The delivery order is scheduled for completion by September 16, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $3,757.37 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Monovisc 88 mg/4 mL syringes. The order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by July 30, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made on a firm fixed-price basis with no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a $24,926.44 delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Monovisc 88 mg/4 mL syringes. This non-set-aside, firm fixed-price contract is classified as a delivery order with an ultimate completion date of July 16, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations as a major pharmaceutical distributor serving federal...
- The U.S. Defense Department's Medical Supply Chain awarded a $24,941.15 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 19, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. As a non-set-aside contract, the award reflects AmerisourceBergen's capability to compete successfully against other...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,060.96 by the Defense Logistics Agency on August 6, 2025, for the supply of Monovisc 88 mg/4 mL syringes. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is scheduled for completion by August 7, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,229.88 on July 29, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This competitive award, with no set-aside designation, represents a firm fixed price contract with an ultimate completion date of July 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- AmerisourceBergen Drug Corp was awarded a $3,443.09 delivery order by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Monovisc 88 mg/4 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded contract, reflecting AmerisourceBergen's demonstrated capability to meet...